M&T Bank’s Elevance Health ELV Stock Holding History

M&T Bank’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.78M	Sell	19,729 -2,202	-10%	-$724K	0.02%	362
2025 Q4	$7.69M	Buy	21,931 +2,546	+13%	+$860K	0.02%	326
2025 Q3	$6.26M	Sell	19,385 -6,035	-24%	-$1.88M	0.02%	341
2025 Q2	$9.89M	Sell	25,420 -1,962	-7%	-$789K	0.03%	295
2025 Q1	$11.9M	Sell	27,382 -2,656	-9%	-$1.07M	0.04%	262
2024 Q4	$11.1M	Sell	30,038 -1,744	-5%	-$730K	0.04%	275
2024 Q3	$16.5M	Sell	31,782 -30,707	-49%	-$16.4M	0.05%	229
2024 Q2	$33.9M	Sell	62,489 -857	-1%	-$453K	0.12%	149
2024 Q1	$32.8M	Sell	63,346 -3,535	-5%	-$1.76M	0.11%	145
2023 Q4	$31.5M	Sell	66,881 -27,413	-29%	-$12.7M	0.12%	149
2023 Q3	$41.1M	Sell	94,294 -336	-0.4%	-$152K	0.16%	120
2023 Q2	$42M	Sell	94,630 -1,614	-2%	-$745K	0.16%	122
2023 Q1	$44.3M	Buy	96,244 +2,979	+3%	+$1.42M	0.17%	120
2022 Q4	$47.8M	Buy	93,265 +5,310	+6%	+$2.7M	0.19%	115
2022 Q3	$40M	Sell	87,955 -4,950	-5%	-$2.37M	0.18%	126
2022 Q2	$42.5M	Buy	92,905 +4,545	+5%	+$2.25M	0.2%	113
2022 Q1	$43.4M	Buy	88,360 +3,644	+4%	+$1.67M	0.19%	117
2021 Q4	$39.3M	Buy	84,716 +744	+0.9%	+$313K	0.17%	133
2021 Q3	$31.3M	Sell	83,972 -2,101	-2%	-$798K	0.14%	144
2021 Q2	$32.9M	Sell	86,073 -5,417	-6%	-$2.07M	0.14%	142
2021 Q1	$32.8M	Sell	91,490 -2,632	-3%	-$846K	0.14%	141
2020 Q4	$30.2M	Buy	94,122 +1,637	+2%	+$502K	0.13%	140
2020 Q3	$24.8M	Buy	92,485 +180	+0.2%	+$48.4K	0.12%	143
2020 Q2	$24.3M	Sell	92,305 -2,896	-3%	-$773K	0.13%	137
2020 Q1	$21.6M	Buy	95,201 +5,702	+6%	+$1.55M	0.13%	144
2019 Q4	$27M	Sell	89,499 -1,472	-2%	-$405K	0.13%	112
2019 Q3	$21.8M	Sell	90,971 -1,139	-1%	-$312K	0.11%	158
2019 Q2	$26M	Sell	92,110 -171	-0.2%	-$46.7K	0.14%	148
2019 Q1	$26.5M	Sell	92,281 -25,157	-21%	-$7.28M	0.14%	142
2018 Q4	$30.8M	Sell	117,438 -310	-0.3%	-$85.2K	0.18%	118
2018 Q3	$32.3M	Buy	117,748 +168	+0.1%	+$43.6K	0.16%	131
2018 Q2	$28M	Buy	117,580 +1,050	+0.9%	+$243K	0.15%	142
2018 Q1	$25.6M	Buy	116,530 +4,946	+4%	+$1.16M	0.14%	146
2017 Q4	$25.1M	Buy	111,584 +6,241	+6%	+$1.33M	0.13%	153
2017 Q3	$20M	Sell	105,343 -277	-0.3%	-$52.7K	0.11%	178
2017 Q2	$19.9M	Buy	105,620 +18,061	+21%	+$3.25M	0.12%	178
2017 Q1	$14.5M	Buy	87,559 +11,489	+15%	+$1.83M	0.09%	202
2016 Q4	$10.9M	Buy	76,070 +56,433	+287%	+$7.56M	0.07%	219
2016 Q3	$2.46M	Sell	19,637 -1,282	-6%	-$166K	0.02%	477
2016 Q2	$2.75M	Sell	20,919 -3,554	-15%	-$486K	0.02%	445
2016 Q1	$3.4M	Sell	24,473 -5,221	-18%	-$698K	0.02%	403
2015 Q4	$4.14M	Buy	29,694 +4,532	+18%	+$624K	0.03%	364
2015 Q3	$3.52M	Buy	25,162 +10,492	+72%	+$1.58M	0.02%	402
2015 Q2	$2.41M	Sell	14,670 -10,515	-42%	-$1.68M	0.01%	578
2015 Q1	$3.89M	Buy	25,185 +12,793	+103%	+$1.82M	0.02%	435
2014 Q4	$1.56M	Sell	12,392 -17,945	-59%	-$2.22M	0.01%	699
2014 Q3	$3.63M	Buy	30,337 +13,037	+75%	+$1.5M	0.02%	461
2014 Q2	$1.86M	Hold	17,300	–	–	0.08%	191
2014 Q1	$1.72M	Hold	17,300	–	–	0.07%	185
2013 Q4	$1.6M	Buy	+17,300	New	+$1.54M	0.07%	199

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

M&T Bank's ELV Position: Q1 2026 in Review

M&T Bank reduced its Elevance Health (ELV) stake by 10% in Q1 2026, selling an estimated $724K and leaving 19,729 shares worth $5.78M. The position accounts for 0.02% of the portfolio, ranked #362.

M&T Bank first reported a position in ELV in Q4 2013 and has held it in 50 quarters since. The position peaked at $47.8M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

M&T Bank held 19,729 shares of Elevance Health worth $5.78M as of Q1 2026.
M&T Bank sold 2,202 Elevance Health shares in Q1 2026, an estimated $724K.
Elevance Health made up 0.02% of M&T Bank's portfolio in Q1 2026, its #362 holding.
M&T Bank first reported a position in Elevance Health in Q4 2013 and has held it in 50 quarters since.
M&T Bank's Elevance Health position peaked at $47.8M in Q4 2022.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.